查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853661

心臟疾病影像设备市场：按技术、最终用户和应用划分 - 全球预测（2025-2032 年）

Coronary Heart Disease Diagnostic Imaging Devices Market by Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，心臟疾病影像市场规模将达到 55.2 亿美元，复合年增长率为 9.98%。

关键市场统计数据
基准年 2024 25.8亿美元
预计年份：2025年 28.4亿美元
预测年份 2032 55.2亿美元
复合年增长率 (%) 9.98%

心臟疾病影像学的综合观点着重于技术、临床工作流程和数据主导决策的整合。

心臟疾病的诊断越来越依赖一系列先进的影像技术，这些技术共同建构的临床影像比任何单一技术单独提供的都更加丰富、细緻。过去十年，影像技术已从解剖结构的简介式成像转变为整合结构、功能和分子资讯的综合评估，从而指导精准治疗。因此，临床医生、医院系统和技术供应商如今所处的环境，决定着设备互通性、影像分析和工作流程整合的成败，而这些因素共同决定临床疗效和商业性可行性。

临床实践面临着在最大限度降低患者风险和简化治疗流程的同时，提供更快、更准确的诊断的压力。技术进步、日益严格的监管以及不断变化的报销机制，都在共同推动那些能够加快诊断速度、减少不必要的侵入性手术并实现长期疾病管理的解决方案获得认可。本引言为执行摘要摘要的其余部分奠定了基础，强调市场成功将取决于那些能够将技术创新与临床效用、工作流程优化和数据主导的决策支援相结合的企业。

因此，相关人员不仅需要了解各个影像处理平台的功能，还需要了解它们如何在复杂的医疗生态系统中发挥作用。从可改善床边照护现场的床边超音波到为介入治疗方案製定提供资讯的高解析度电脑断层超音波，每种影像技术都对连续性医疗服务做出贡献。以下章节将综合分析转型趋势、贸易政策影响、市场区隔差异、区域差异、企业策略以及实用建议，旨在为心臟疾病影像领域的领先地位指明方向。

人工智慧、混合成像、安全优化和基于价值的采购等领域的进步，正在从根本上重塑诊断路径和供应商竞争格局。

心臟疾病影像学领域再形成，这些因素正在改变临床医生检测、量化和监测疾病的方式。人工智慧和先进的影像分析技术正从先导计画走向临床工作流程，实现斑块自动表征、灌注定量和分诊优先排序，从而缩短解读时间并提高结果的可重复性。同时，结合解剖和功能资讯的混合和多模态成像策略，例如CT衍生的血流储备分数和PET/CT联合通讯协定，正在提高诊断的准确性并减少对侵入性血管造影术的依赖。

另一个重要的转变是追求降低辐射剂量和保障病人安全。重建演算法、检测器设计和造影剂使用方面的创新，使得在显着降低辐射和造影用量的情况下获得高保真影像成为可能，从而扩大了先进成像技术在体弱或併发症疾病患者中的应用范围。同时，床边快速成像和小型化系统的出现，特别是在超音波和低场磁振造影领域，正在使诊断分散化，并支持在门诊和急诊环境中快速做出决策。

在营运层面，支付者和医疗系统正在加速采用以价值为导向的采购模式，优先考虑疗效、效率和总医疗成本。这促使供应商提供配套服务协议、绩效保证和云端订阅服务。此外，随着供应商要求自身俱备应对地缘政治动盪和成本波动的能力，全球供应链优化和本地化生产已成为战略要务。这些转变共同拓展了临床能力，同时也加剧了对整合性、扩充性和可验证的临床价值的竞争。

评估关税驱动的采购压力、供应链重组和成本转嫁动态如何影响设备设计、分销和临床应用。

美国在这​​一年实施的关税政策对诊断影像技术的采购、製造策略和经济效益产生了连锁反应。由于关税导致进口零件成本上升，製造商不得不重新评估其全球筹资策略，加快供应商多元化，并在许多情况下寻求关键子组件的近岸外包或国内生产。这些供应链调整改变了前置作业时间、资金配置以及不同影像处理平台的相对成本竞争力。

随着某些进口设备和组件的采购成本增加，医疗服务提供者和综合护理网路更加关注整体拥有成本，倾向于选择那些承诺长期可维护性、远距离诊断和模组化升级路径的系统。同时，一些供应商为了维护其市场地位而自行承担了关税相关成本，而另一些供应商则将增加的成本转嫁给了买家，从而在医院、诊断中心和门诊机构之间造成了价格差异。

关税也影响了创新路径。预算限制和采购的不确定性促使原始设备製造商 (OEM) 减少对高关税零件的依赖，转而采用强调软体主导差异化的平台设计。与监管机构的关係也发生了变化，在资金週期受限的情况下，企业优先考虑能够快速产生高价值临床回报的设备和改进方案。最后，贸易政策鼓励製造商与区域经销商建立策略伙伴关係，以减少海关手续的复杂性并建立更可预测的合约安排。综上所述，这些影响揭示了贸易政策如何透过促进供应链韧性、设计模组化和商业灵活性来加速各行业的结构性变革。

透过详细的細項分析，将设备架构、临床应用案例和护理环境要求连结起来，从而揭示精准的采用驱动因素和技术契合度。

细緻的细分框架揭示了临床需求、技术能力和购买行为之间的交集，从而影响产品策略和市场推广计划。按技术划分，该领域包括电脑断层扫描（CT）、磁振造影）、光学显像模式、正子断层扫描（PET）、单光子发射断层扫描（SPECT）和超音波。特别是CT，其架构各不相同，例如双源CT、多切面CT和单切片电脑断层扫描器 ，每种架构在时间分辨率、空间分辨率和吞吐量之间各有优劣。 MRI则根据磁场强度进一步细分：5特斯拉、3特斯拉和>3特斯拉/点，这会影响讯号杂讯比、采集速度以及对高阶组织表征通讯协定的适用性。磁振造影成像技术包括冠状动脉内成像方式，例如血管内光学相干断层扫描（IVOCT）和近红外线光谱（NIR），这些技术可以评估斑块的微观结构和成分，是对大血管成像的补充。超音波诊断设备种类繁多，包括 2D 平台、 3D容积成像和用于量化血流动力学的多普勒功能。

从终端使用者的观点来看，门诊医疗中心、诊断中心、医院和专科诊所的采用模式各不相同，每种环境优先考虑的方面也不同，例如资本密集度、吞吐量和临床灵活性。诊断目标分为解剖学评估、灌注成像和活性成像，而灌注通讯协定本身又分为静止灌注和负荷灌注模式，每种模式对硬体和软体的要求都不同。了解这些细分领域有助于临床医生和采购团队权衡各种利弊，例如速度与准确性、便携性与全面功能以及资本投资与单次扫描成本。因此，供应商和医疗系统可以透过将产品功能与特定的临床工作流程和采购限制相匹配，实现更清晰的差异化并加快产品推广。

区域医疗保健基础设施、报销框架和临床重点如何推动全球市场中不同的诊断影像应用模式

医疗基础设施、法规环境和支付模式的差异造就了区域性的动态变化，进而影响创新轨迹和临床应用的速度。在美洲，对三级医疗机构的高额资本投入以及对微创治疗路径的重视，推动了对先进电脑断层扫描器）、高场磁振造影（MRI）和混合成像解决方案的需求，这些方案旨在减少不必要的侵入性诊断。随着医疗服务从学术中心转移到社区医院和门诊机构，人们对能够将诊断能力扩展到传统医院以外的可携式、经济高效的诊断设备也表现出浓厚的兴趣。

欧洲、中东和非洲的情况差异很大。西欧成熟的医疗体係正迅速采用剂量降低技术和人工智慧驱动的分析方法，而中东部分地区则优先考虑旗舰三级医疗投资和新兴临床网路。在非洲，医疗服务的可近性和可靠性往往是首要考虑因素，这推动了稳健、低维护成本的系统和远距影像伙伴关係的普及，从而增强了资源有限的专科医生的能力。该地区的报销结构和跨境监管协调对采购週期和供应商策略有显着影响。

亚太地区依然是一个充满活力的成长区域，这得益于其庞大的人口基数、不断增长的中阶对先进诊断的需求以及各国对医疗基础设施的大力投入。区域製造商和国际原始设备製造商（OEM）在服务模式、性价比和区域伙伴关係展开了激烈的竞争。儘管互通性、基于云端的影像共用和培训计画仍然是各地区推广应用的关键，但高端三级医疗投资与分散式诊断服务之间的平衡在不同地区差异显着，从而形成了各自独特的商业性模式。

为什么企业正从以硬体为中心的销售模式转向整合软体、服务和临床证据的整合平台，以确保与机构建立长期伙伴关係？

冠状动脉成像领域的企业策略正围绕着一系列实际需求趋于一致：平台模组化、服务和软体带来的持续收入、临床证据生成以及策略伙伴关係。领先的製造商正在拓展业务范围，不再局限于硬件，而是提供云端分析、承包安装和维护合约以及临床医生培训项目，从而加速实现临床价值。这种转变反映出人们逐渐意识到，长期的客户关係和数据主导的服务往往比一次性的设备销售更能带来更高的终身价值。

对于那些寻求快速进入互补技术领域的公司而言，研发、策略合作和有针对性的收购仍然是关键途径，例如专注于斑块检测的人工智慧新兴企业公司和开发用于量化冠状动脉灌注的软体的专业公司。此外，策略投资者优先考虑那些能够展现清晰的临床结果、监管审批路径以及可在各种医疗环境中可扩展部署模式的公司。差异化服务，例如远端系统健康监测、预测性维护以及将供应商奖励与医疗服务提供者目标相结合的按绩效付费合同，正变得日益重要。

最后，对技术、临床和监管人才的竞争正在塑造创新管道。那些将临床领域专业知识与软体和云端工程能力结合的机构，更有能力提供满足多学科心臟团队需求的整合解决方案。因此，现今的产品蓝图通常体现为硬体改进、模组化软体升级以及生态系统伙伴关係的结合，旨在显着提升诊断准确性、工作流程效率和患者体验。

为供应商和医疗系统提供可操作的策略重点，以平衡创新、供应链韧性和基于价值的商业模式，从而加速采用。

为了最大限度地提高应用率和长期价值，行业领导者应采取多管齐下的策略，重点关注临床结果、营运弹性以及灵活的商业模式。首先，应优先投资于人工智慧驱动的影像分析和工作流程自动化，以显着缩短阅片时间并降低阅片者之间的差异。其次，应重新设计产品系列，强调模组化设计，使核心平台可以透过软体和模组化硬体的更换进行升级，而无需进行大规模的资本投入。

第三，我们将透过供应商多元化、寻找替代零件供应商以及评估关键製造流程的近岸外包方案，来增强供应链的韧性。这些措施将降低我们受关税波动和物流中断的影响，同时提高客户前置作业时间的可预测性。第四，我们将透过扩展包含分析、运作保障和培训的服务和订阅产品，创造经常性收入来源，并将供应商奖励与临床和营运结果挂钩。第五，我们将寻求与医疗系统和支付方建立有针对性的伙伴关係，以产生支持基于价值的合约的真实世界证据，并开展合作试点项目，以证明降低侵入性手术率和提高患者吞吐量的有效性。

最后，要根据不同地区和医疗环境调整市场开发方法，因为不同三级医院、诊断中心、门诊诊所和专科诊所的采购驱动因素各不相同。投资于临床医师教育、远距影像网路和区域服务能力将加速专科服务受限市场的普及，而打包服务和疗效保证则更能引起重视整体医疗成本的医疗系统的共鸣。

一个严谨的混合方法研究框架，结合了临床医生访谈、技术文献综述、供应链图谱绘製和情境分析，以检验策略结论。

本分析整合了多方面的证据，以确保方法的严谨性和实际应用价值。主要研究包括对临床医生、采购负责人和设备工程师进行结构化访谈，以了解临床需求、采购限制和技术偏好等第一线情况。此外，专家咨询小组也参与了访谈，检验了人工智慧整合、混合成像技术应用以及贸易政策变化对营运的影响等新兴主题。次要分析则利用了同侪审查文献、监管申报文件、设备技术规范和已发布的临床指南，对不同影像方式的性能特征和临床效用进行三角验证。

为了解商业和供应链的影响，本研究采用了定性供应商分析、合约审查摘要以及关税和物流中断情境分析。研究还考察了产品蓝图和专利趋势，以确定技术差异化领域和潜在的竞争切入点。最后，研究结果透过情境规划研讨会进行了压力测试，模拟了不同报销和投资环境下的产品采纳路径，为寻求将产品策略与临床需求和采购实际情况相协调的相关人员提供了明确的指南。

总结性报告强调，必须将临床检验、模组化产品策略和服务主导的商业性模式结合，才能实现长期价值。

摘要：心臟疾病影像生态系统正处于曲折点，技术成熟度、数据分析和采购模式的转变正在共同重塑临床路径。最成功的方案是将高保真影像技术与人工智慧驱动的分析、模组化升级以及使供应商激励机制与临床结果一致的服务模式奖励。贸易政策的波动和区域基础设施的差异既带来了风险也带来了机会，因此需要供应链具备韧性，并制定与区域战略相符的奖励。

因此，从设备製造商到医院高管，相关人员必须优先考虑那些能够加快诊断速度、降低手术风险并显着改善患者预后，同时保持营运灵活性的投资。透过专注于模组化平台、循证伙伴关係以及持续的服务收入，各机构可以在日益以互通性和基于价值的采购为驱动力的市场中建立稳固的地位。总而言之，结论显而易见：临床检验与可扩展的商业模式相结合，将决定谁将引领下一波冠心病诊断创新浪潮。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 利用人工智慧演算法对冠状动脉CT血管造影术中的斑块进行自动评估
  • 透过整合光子计数CT技术，提高了冠状动脉斑块的可视化和定量分析能力。
  • FFR-CT非侵入性血流储备分数的出现，为指导冠状动脉介入治疗决策提供了可能。
  • 低剂量心臟CT通讯协定的进展可最大限度地减少常规冠状动脉筛检期间的辐射暴露
  • 改良床边手持式超音波设备以进行冠状动脉血流储备评估
  • 利用PET/MRI混合系统，结合冠状动脉发炎的解剖影像和分子影像。
  • 开发靶向易损动脉粥样硬化斑块斑块标记的新型分子PET示踪剂
  • 云端基础平台的远端心臟影像分析和远距心臟病学协作的实施
  • 将3D列印技术应用于患者特异性冠状动脉模型术前规划
  • 基于深度学习的工作流程自动化，可高效产生心臟影像报告

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按技术分類的心臟疾病成像设备市场

  • CT
    • 双源CT
    • 多切面CT
    • 单切片电脑断层扫描器
  • MRI
    • 1.5T
    • 3T
    • 3吨或以上
  • 光学成像
    • IVOCT
    • NIRS
  • PET
  • SPECT
  • 超音波
    • 2D
    • 3D
    • 多普勒

9. 依最终用户分類的心臟疾病影像设备市场

  • 门诊治疗中心
  • 诊断中心
  • 医院
  • 专科诊所

第十章：心臟疾病影像设备市场（依应用领域划分）

  • 解剖学评估
  • 灌注影像
    • 静止状态下的灌注
    • 压力灌注
  • 活性成像

第十一章心臟疾病影像设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章心臟疾病诊断设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

13. 各国心臟疾病影像设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE Healthcare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Fujifilm Holdings Corporation
    • Hitachi, Ltd.
    • Shimadzu Corporation
    • Carestream Health, Inc.
    • Agfa-Gevaert NV
    • Esaote SpA
Product Code: MRR-8C74ADFC03A3

The Coronary Heart Disease Diagnostic Imaging Devices Market is projected to grow by USD 5.52 billion at a CAGR of 9.98% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.58 billion
Estimated Year [2025] USD 2.84 billion
Forecast Year [2032] USD 5.52 billion
CAGR (%) 9.98%

An integrative perspective on coronary heart disease diagnostic imaging that highlights the convergence of technology, clinical workflows, and data-driven decision making

The diagnosis of coronary heart disease increasingly relies on an array of advanced imaging modalities that together create a richer, more nuanced clinical picture than any single technique could provide alone. Over the last decade, imaging has shifted from standalone anatomical snapshots to integrated assessments that combine structural, functional, and molecular information to guide precision care. As a result, clinicians, hospital systems, and technology vendors now operate in an environment where device interoperability, image analytics, and workflow integration determine both clinical impact and commercial viability.

In clinical practice, the imperative is clear: deliver faster, more accurate diagnosis while minimizing patient risk and streamlining care pathways. Technological advances, regulatory rigor, and evolving reimbursement practices are converging to reward solutions that shorten time to diagnosis, reduce unnecessary invasive procedures, and enable longitudinal disease management. This introduction frames the remainder of the executive summary by emphasizing that successful market actors will be those who align engineering innovation with clinical utility, workflow optimization, and data-driven decision support.

Consequently, stakeholders must understand not only the capabilities of individual imaging platforms but also how they function within complex care ecosystems. From point-of-care ultrasound that improves bedside triage to high-resolution computed tomography that informs interventional planning, each modality contributes to a continuum of care. The subsequent sections synthesize transformative trends, trade policy impacts, segmentation nuances, regional variations, corporate strategies, and practical recommendations that together chart a pathway for leaders in coronary heart disease diagnostic imaging.

How advances in artificial intelligence, hybrid imaging, safety optimization, and value-based procurement are fundamentally reshaping diagnostic pathways and vendor competition

The landscape of coronary heart disease diagnostic imaging is being reshaped by several convergent forces that are transforming how clinicians detect, quantify, and monitor disease. Artificial intelligence and advanced image analytics have moved from pilot projects into clinical workflows, enabling automated plaque characterization, perfusion quantification, and triage prioritization that reduce interpretation time and enhance reproducibility. Simultaneously, hybrid and multimodal imaging strategies that pair anatomical and functional information-such as computed tomography-derived fractional flow reserve and combined PET/CT protocols-are increasing diagnostic confidence and reducing the reliance on invasive angiography.

Another pivotal shift is the relentless drive toward dose reduction and patient safety. Innovations in reconstruction algorithms, detector design, and contrast usage are allowing for high-fidelity images at markedly lower radiation and contrast loads, which broadens the suitability of advanced imaging for frail and comorbid populations. At the same time, the emergence of point-of-care and compact systems, particularly in ultrasound and lower-field MR, is decentralizing diagnostics and enabling faster decision-making in ambulatory and emergency settings.

Operationally, payers and health systems are accelerating adoption of value-based procurement models that prioritize outcomes, throughput, and total cost of care. This is prompting vendors to offer bundled service contracts, performance guarantees, and cloud-enabled subscription services. Finally, global supply chain optimization and localized manufacturing are becoming strategic imperatives as vendors seek resilience against geopolitical disruption and cost volatility. In combination, these shifts are expanding clinical capability while intensifying competition around integration, scalability, and demonstrable clinical value.

Assessing how tariff-driven procurement pressures, supply chain realignments, and cost pass-through dynamics are influencing device design, distribution, and clinical adoption

United States tariff measures implemented in the year in question have had a cascading impact on procurement, manufacturing strategies, and the economics of diagnostic imaging technologies. Tariff-induced cost increases for imported components prompted manufacturers to reassess global sourcing strategies, accelerate supplier diversification, and in many cases explore nearshoring or domestic production for critical subassemblies. These supply chain adaptations have altered lead times, capital allocation, and the relative cost competitiveness of different imaging platforms.

As procurement costs rose for certain imported devices and parts, healthcare providers and integrated delivery networks intensified scrutiny of total cost of ownership, favoring systems that promised long-term serviceability, remote diagnostics, and modular upgrade paths. In parallel, some vendors absorbed tariff-related expenses to protect their market positioning, while others passed incremental costs to purchasers, creating differential pricing pressure across hospitals, diagnostic centers, and ambulatory settings.

Tariffs also influenced innovation pathways. Budgetary constraints and procurement unpredictability pushed OEMs toward platform designs that reduced reliance on tariff-exposed components and emphasized software-driven differentiation. Regulatory interactions shifted as well, with companies prioritizing devices and modifications that offered quick, high-value clinical returns within constrained capital cycles. Finally, trade policy fostered strategic partnerships between manufacturers and regional distributors to mitigate customs complexity and to establish more predictable contractual arrangements. Taken together, these effects underscore that trade measures can accelerate structural change across the industry by catalyzing supply chain resilience, design modularity, and commercial flexibility.

Detailed segmentation analysis linking device architectures, clinical use cases, and care setting requirements to reveal precise adoption drivers and technology fit

A nuanced segmentation framework reveals where clinical demand intersects with technological capability and purchasing behavior, providing clarity for product strategy and go-to-market planning. When examined by technology, the field comprises computed tomography, magnetic resonance imaging, optical imaging modalities, positron emission tomography, single-photon emission computed tomography, and ultrasound. Computed tomography in particular is differentiated by architectures such as dual-source CT, multi-slice CT, and single-slice CT, each offering distinct trade-offs between temporal resolution, spatial resolution, and throughput. Magnetic resonance imaging is further stratified by field strength categories of one point five tesla, three tesla, and above three tesla, which influence signal-to-noise, acquisition speed, and suitability for advanced tissue characterization protocols. Optical imaging techniques include intracoronary modalities such as intravascular optical coherence tomography and near-infrared spectroscopy, which provide microstructural and compositional plaque assessment that complements macrovascular imaging. Ultrasound systems vary across two-dimensional platforms, three-dimensional volumetric imaging, and Doppler capabilities that quantify flow dynamics.

Looking through the lens of end users, adoption patterns diverge across ambulatory care centers, diagnostic centers, hospitals, and specialty clinics, with each setting prioritizing a different mix of capital intensity, throughput, and clinical flexibility. Diagnostic objectives cluster into anatomical assessment, perfusion imaging, and viability imaging, where perfusion protocols themselves bifurcate into resting perfusion and stress perfusion paradigms that drive different hardware and software requirements. Understanding these segments together illuminates the trade-offs clinicians and procurement teams weigh: speed versus precision, portability versus comprehensive capability, and capital expenditure versus per-scan economics. Consequently, vendors and health systems that map product features to specific clinical workflows and procurement constraints will achieve clearer differentiation and higher adoption velocity.

How regional healthcare infrastructure, reimbursement frameworks, and clinical priorities are driving divergent adoption models for diagnostic imaging across global markets

Regional dynamics are shaping both the trajectory of innovation and the pace of clinical uptake, driven by variations in healthcare infrastructure, regulatory environments, and payer models. In the Americas, high levels of capital investment in tertiary centers and a strong emphasis on minimally invasive care pathways are driving demand for advanced computed tomography, high-field magnetic resonance systems, and hybrid imaging solutions that reduce unnecessary invasive diagnostics. Transitioning from academic centers to community hospitals and ambulatory settings, there is also significant interest in portable, cost-effective modalities that can extend diagnostic capability outside traditional hospital walls.

Europe, Middle East & Africa exhibits considerable heterogeneity: established Western European healthcare systems are rapidly adopting dose-reduction technologies and AI-enabled analytics, while parts of the Middle East prioritize flagship tertiary investments and emerging clinical networks. In Africa, the imperative often centers on access and reliability, pushing adoption toward robust, low-maintenance systems and tele-radiology partnerships that can amplify limited specialist capacity. Reimbursement structures and cross-border regulatory harmonization in this region exert a strong influence on procurement cycles and vendor strategies.

Asia-Pacific continues to be a dynamic growth arena, propelled by large population bases, expanding middle-class demand for advanced diagnostics, and national investments in healthcare infrastructure. Regional manufacturers and international OEMs compete aggressively on service models, price-performance ratios, and local partnerships. Across all regions, interoperability, cloud-enabled image sharing, and training programs remain central to adoption, but the balance between high-end tertiary investments and decentralized diagnostic access varies significantly by geography, shaping distinct commercial approaches.

Why companies are shifting from hardware-centric sales to integrated platforms that combine software, services, and clinical evidence to secure long-term institutional partnerships

Corporate strategies within the coronary diagnostic imaging arena are converging around a set of practical imperatives: platform modularity, recurring revenue through service and software, clinical evidence generation, and strategic partnerships. Leading manufacturers are expanding beyond hardware to offer cloud-enabled analytics, turnkey installation and maintenance contracts, and clinician training programs that accelerate time to clinical value. This shift reflects an understanding that long-term customer relationships and data-driven services often yield higher lifetime value than one-time equipment sales.

Mergers, strategic alliances, and targeted acquisitions continue to be a primary route for companies seeking rapid entry into complementary technologies, such as AI startups focused on plaque detection or specialist firms developing coronary perfusion quantification software. Additionally, strategic investors are placing emphasis on companies that demonstrate clear clinical outcomes, regulatory clearance pathways, and scalable deployment models for varied care settings. Service differentiation increasingly includes remote monitoring of system health, predictive maintenance, and outcome-linked contracting that aligns vendor incentives with institutional goals.

Finally, competition for talent-engineers, clinical specialists, and regulatory experts-is shaping innovation pipelines. Organizations that combine clinical domain expertise with software and cloud engineering capabilities are better positioned to deliver integrated solutions that meet the needs of multi-disciplinary cardiac teams. As a result, product roadmaps now commonly reflect a combination of hardware improvements, modular software upgrades, and ecosystem partnerships aimed at delivering measurable improvements in diagnostic accuracy, workflow efficiency, and patient experience.

Actionable strategic priorities for vendors and health systems that balance innovation, supply chain resilience, and value-based commercial models to accelerate adoption

Industry leaders should adopt a multi-pronged strategy that emphasizes clinical outcomes, operational resilience, and flexible commercial models to maximize adoption and long-term value. First, prioritize investments in AI-driven image analysis and workflow automation that demonstrably reduce interpretation time and inter-reader variability; pilot projects should be designed to capture clinical endpoints and economic benefits to enable reimbursement discussions and procurement approvals. Second, redesign product portfolios to emphasize modularity, enabling core platforms to be upgraded via software or modular hardware swaps rather than full capital replacement, which preserves customer relationships and reduces procurement friction.

Third, strengthen supply chain resilience by diversifying suppliers, qualifying alternative component sources, and evaluating nearshoring options for critical manufacturing steps. These measures will reduce exposure to tariff volatility and logistical disruption while improving lead time predictability for customers. Fourth, expand service and subscription offerings that bundle analytics, uptime guarantees, and training, thereby creating recurring revenue streams and aligning vendor incentives with clinical and operational outcomes. Fifth, pursue targeted partnerships with health systems and payers to generate real-world evidence that supports value-based contracting and to create joint pilots that illustrate reduced invasive procedural rates or improved patient throughput.

Finally, tailor go-to-market approaches by region and care setting, recognizing the different procurement drivers across tertiary hospitals, diagnostic centers, ambulatory care sites, and specialty clinics. Investments in clinician education, tele-radiology networks, and local service capabilities will accelerate adoption in markets with constrained specialist availability, while bundled offerings and outcome guarantees will resonate in systems prioritizing total cost of care.

A rigorous mixed-methods research framework combining clinician interviews, technical dossier review, supply chain mapping, and scenario analysis to validate strategic conclusions

This analysis synthesizes multiple evidence streams to ensure methodological rigor and practical relevance. Primary research included structured interviews with clinicians, procurement leaders, and device engineers to capture frontline insights into clinical requirements, procurement constraints, and technology preferences. These conversations were complemented by expert advisory panels that validated emerging themes such as AI integration, hybrid imaging adoption, and the operational impact of trade policy changes. Secondary analysis drew upon peer-reviewed literature, regulatory filings, device technical specifications, and published clinical guidelines to triangulate performance characteristics and clinical utility across modalities.

To understand commercial and supply chain implications, the research incorporated qualitative supplier mapping, contract review summaries, and scenario analysis of tariff and logistics disruptions. Product roadmaps and patent trends were examined to identify areas of technological differentiation and potential competitive entry points. Finally, findings were stress-tested through scenario planning workshops that modeled adoption pathways across different reimbursement and investment environments, providing robust directional guidance for stakeholders seeking to align product strategy with clinical demand and procurement realities.

Concluding synthesis that underscores the imperative to align clinical validation, modular product strategy, and service-led commercial approaches to capture long-term value

In summary, the diagnostic imaging ecosystem for coronary heart disease is at an inflection point where technological maturity, data analytics, and changing procurement models are collectively redefining clinical pathways. The most successful approaches will integrate high-fidelity imaging modalities with AI-enabled analysis, modular upgradeability, and service models that align vendor incentives with clinical outcomes. Trade policy fluctuations and regional differences in infrastructure create both risk and opportunity, incentivizing supply chain resilience and tailored regional strategies.

Stakeholders-from device manufacturers to hospital executives-must therefore prioritize investments that reduce time to diagnosis, lower procedural risk, and demonstrably improve patient outcomes while maintaining operational flexibility. By focusing on modular platforms, evidence-generation partnerships, and recurrent service revenues, organizations can build defensible positions in a market increasingly driven by interoperability and value-based procurement. The overarching conclusion is clear: combining clinical validation with scalable commercial models will determine who leads the next wave of diagnostic innovation in coronary care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of artificial intelligence algorithms for automated plaque characterization in coronary CT angiography
  • 5.2. Integration of photon-counting computed tomography to improve coronary plaque visualization and quantification
  • 5.3. Emergence of FFR-CT noninvasive fractional flow reserve assessment to guide coronary intervention decisions
  • 5.4. Advancements in low-dose cardiac CT protocols to minimize radiation exposure in routine coronary screening
  • 5.5. Expansion of point-of-care handheld ultrasound devices for bedside coronary flow reserve assessment
  • 5.6. Utilization of hybrid PET/MRI systems for combined anatomical and molecular imaging of coronary inflammation
  • 5.7. Development of novel molecular PET tracers targeting vulnerable atherosclerotic plaque biomarkers
  • 5.8. Implementation of cloud-based platforms for remote cardiac imaging analytics and telecardiology collaboration
  • 5.9. Integration of 3D printing technology for patient-specific coronary artery phantoms in preprocedural planning
  • 5.10. Incorporation of deep learning-driven workflow automation to streamline cardiac imaging report generation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Heart Disease Diagnostic Imaging Devices Market, by Technology

  • 8.1. CT
    • 8.1.1. Dual-Source CT
    • 8.1.2. Multi-Slice CT
    • 8.1.3. Single-Slice CT
  • 8.2. MRI
    • 8.2.1. 1.5T
    • 8.2.2. 3T
    • 8.2.3. Above 3T
  • 8.3. Optical Imaging
    • 8.3.1. IVOCT
    • 8.3.2. NIRS
  • 8.4. PET
  • 8.5. SPECT
  • 8.6. Ultrasound
    • 8.6.1. 2D
    • 8.6.2. 3D
    • 8.6.3. Doppler

9. Coronary Heart Disease Diagnostic Imaging Devices Market, by End User

  • 9.1. Ambulatory Care Centers
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Coronary Heart Disease Diagnostic Imaging Devices Market, by Application

  • 10.1. Anatomical Assessment
  • 10.2. Perfusion Imaging
    • 10.2.1. Resting Perfusion
    • 10.2.2. Stress Perfusion
  • 10.3. Viability Imaging

11. Coronary Heart Disease Diagnostic Imaging Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Coronary Heart Disease Diagnostic Imaging Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Coronary Heart Disease Diagnostic Imaging Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. GE Healthcare
    • 14.3.2. Siemens Healthineers AG
    • 14.3.3. Koninklijke Philips N.V.
    • 14.3.4. Canon Medical Systems Corporation
    • 14.3.5. Fujifilm Holdings Corporation
    • 14.3.6. Hitachi, Ltd.
    • 14.3.7. Shimadzu Corporation
    • 14.3.8. Carestream Health, Inc.
    • 14.3.9. Agfa-Gevaert N.V.
    • 14.3.10. Esaote S.p.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 256. E